Skip to main content

Test Price

450 AED

✅ Home Collection Available

Immunophenotyping by Flow Cytometry (IgM Heavy Chain, Cytoplasmic) Test in UAE | 450 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee:

99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing.

Premium Logistics:

Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.

Clinical Guidance:

Telephonic post‑test clinical interpretation and result consultation included.

Insurance Direct Billing:

Instant verification via WhatsApp +971 54 548 8731. Fully compliant with UAE PDPL privacy safeguards.

Test Overview & Methodology

The Immunophenotyping by Flow Cytometry (Cytoplasmic IgM Heavy Chain) test precisely detects intracellular immunoglobulin M heavy chain in B‑cells using fluorescent flow cytometry, essential for diagnosing B‑cell lymphomas, Waldenström macroglobulinemia, and chronic lymphocytic leukemia. This same‑day UAE assay combines DHA‑endorsed methodology with expert telephonic interpretation to guide timely therapy.

Feature Our Test (Flow Cytometry, Cytoplasmic IgM) Closest Alternative (Immunofixation / IHC)
Detection Specificity Single‑cell cytoplasmic IgM heavy chain, clonality assessment with ≥99% sensitivity Serum‑level monoclonal IgM; cannot distinguish membrane vs. cytoplasmic expression
Methodology Fluorescent flow cytometry (LC‑MS/MS‑verified cytometric gating) Gel electrophoresis + immunofixation or manual IHC scoring
Turnaround Time Same day (sample by 9 am) 2‑5 working days
Clinical Scope B‑cell neoplasms, MRD monitoring, therapy selection Limited to paraprotein identification; no cellular resolution

Physician Insight & Safety Protocols

“As a DHA‑licensed pathologist, I understand the anxiety that accompanies a possible lymphoproliferative diagnosis. This cytoplasmic IgM flow cytometry test provides definitive clonality evidence, but results must always be correlated with clinical findings, imaging, and haematological parameters. A negative result does not entirely exclude disease, and a positive result should be integrated into a comprehensive care plan. Please use these insights to initiate a collaborative dialogue with your oncologist, not to self‑diagnose.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

⚠ Medication Advisory

Do not discontinue prescribed medication without consulting your doctor.

Abruptly stopping anticoagulants, immunosuppressants, or chemotherapy may lead to life‑threatening complications. The test requires current medication information to be recorded on the request form; this does not imply advice to alter therapy.

🛑 Critical Safety & Exclusion Criteria

  • Exclusion Criteria: Hemolyzed, clotted, or grossly lipemic samples are rejected. Inappropriately collected tubes (non‑EDTA/non‑sodium heparin) or volume below the absolute minimum (less than 2 mL blood / 1 mL bone marrow) will invalidate the test.
  • Sample Stability: Transport immediately at 18–22°C. DO NOT REFRIGERATE OR FREEZE. Failure to maintain ambient temperature causes cell lysis and false‑negative cytoplasmic staining.
  • Specimen Labeling: Test request form must clearly state time, date, and clinical details (including any suspected diagnosis or prior IgM monoclonal gammopathy). Unlabeled samples are discarded per UAE biobank safety regulations.
  • 🚨 ER Red Flags: If, before testing, you experience new‑onset shortness of breath, bone pain crisis, unexplained bleeding, or neurological symptoms (vision changes, confusion), seek emergency medical attention immediately – these may indicate hyperviscosity or leukostasis syndrome that transcend outpatient testing.

Patient FAQ & Clinical Guidance

1. What does a positive cytoplasmic IgM heavy chain result mean for my diagnosis?

A positive cytoplasmic IgM signal confirms clonal B‑cell restriction, typically seen in Waldenström macroglobulinemia, certain diffuse large B‑cell lymphomas, and chronic lymphocytic leukemia with plasmacytic differentiation, but final diagnosis requires correlation with bone marrow biopsy and serum IgM levels.

2. How should I prepare for the blood or bone marrow collection?

No fasting is required; however, you must provide a complete medication list and clinical history on the request form, and if both peripheral blood and bone marrow samples are drawn, the blood tubes must be labelled “peripheral blood – EDTA” and “peripheral blood – sodium heparin” distinctly and transported immediately at room temperature.

3. Can this test be used to monitor my treatment response over time?

Yes, serial cytoplasmic IgM flow cytometry is highly effective for minimal residual disease (MRD) monitoring in B‑cell malignancies, because the clonal B‑cell population’s cytoplasmic IgM intensity correlates with treatment efficacy and relapse risk.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance

This test is performed under the regulatory framework of the Dubai Health Authority (DHA). All clinical and personal data handling adheres to:

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
  • Federal Decree-Law No. 4 of 2016 on Medical Liability for patient safety and clinical governance

Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Facility License No: 1143

Clinical & Logistical Metadata

Test Name Immunophenotyping by Flow Cytometry (IgM Heavy Chain, Cytoplasmic)
Price (AED) 450
Turnaround Time Same day (sample received by 9:00 AM)
Sample Type / Matrix Whole Blood (EDTA & Sodium Heparin) or Bone Marrow (Sodium Heparin) – Hospital Extraction Only
Methodology Used Flow Cytometry with cytoplasmic IgM heavy chain detection
ICD-10-CM Code C91.1
LOINC Code 74572-8
DHA Facility License & Laboratory Address License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians